James F. Polewaczyk is President & VP at IDEXX LABORATORIES INC /DE (IDXX). They have made 8 open-market trades across 1 company since 2011, most recently 2024-03-06.
CIK 0001389046
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IDXX | 10,711 | $6.0M |
Shares reported on the most recent Form 4, priced at the 2024-03-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IDXX | SELL | 2024-03-06 | 2024-03-07 | $558.44 | $9.1M | -5.4% | -8.9% | -12.2% |
| IDXX | SELL | 2023-12-07 | 2023-12-08 | $521.92 | $10.4M | +1.5% | +2.3% | +6.0% |
| IDXX | SELL | 2023-08-29 | 2023-08-31 | $510.58 | $23.1M | -11.2% | -16.5% | -9.6% |
| IDXX | SELL | 2021-11-29 | 2021-12-01 | $633.00 | $2.9M | +1.8% | +10.7% | -10.0% |
| IDXX | SELL | 2021-05-28 | 2021-06-01 | $561.91 | $11.2M | +6.8% | +16.8% | +25.5% |
| IDXX | SELL | 2020-05-11 | 2020-05-12 | $298.85 | $9.7M | +2.1% | +3.5% | +30.7% |
| IDXX | SELL | 2012-08-31 | 2012-09-05 | $95.01 | $519K | -6.8% | -1.7% | -1.7% |
| IDXX | SELL | 2011-02-17 | 2011-02-22 | $77.60 | $1.3M | -6.8% | -1.7% | -1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.